ArticleCellular & molecular biology letters2026

Bannakunin: a dual-target Kunitz inhibitor bridging anticoagulation (FXa/XIIa) and anti-platelet (α2β1/P2Y12) pathways.

Miao He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.